Stremble Ventures is based in Cyprus at the forefront of Medical research. We are a research and development-orientated company that offer a range of advanced analytics, bioinformatics, and software engineering expertise for clinical trials and medical research. Our team is comprised of computer scientists, clinicians, bioinformaticians, statisticians and molecular biologists which use advanced analytics, bioinformatics, and software engineering to unlock crucial medical insights. We go beyond data collection, wielding sophisticated methods to mine vast datasets from clinical trials and research studies, extracting hidden patterns and correlations that hold the key to medical breakthroughs. Bioinformatics acts as our bridge, translating complex biological data into a digital language researchers can understand. Furthermore, Stremble develops specialized software tools to manage, analyze and interpret this data, accelerating the pace of discovery. More specifically, the STRAA platform, developed in-house, offers versatile applications that can be applied to: elucidate molecular interactions and pathways, distribute deterministic and stochastic numerical simulations, build personalized models from comprehensive biological datasets, facilitate drug discovery and accelerate drug developments. We have a proven track record of over 17 clinical trials supported and some that are currently ongoing. We offer expertise in the study design of clinical trials and the optimization of statistical power, navigating ethical considerations, to meet local and international regulation as well as prioritizing data protection and minimizing risks to study participants. Our global network of collaboration with academic and industrial partners allows us to deliver innovative biotechnological and digital solutions.
